Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma
2020 · BMC Cancer · 38 citations
https://doi.org/10.1186/s12885-020-6612-2
K
Kyung Ju Ryu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
841
Citations
17
h-index
23
i10-index
Kyung Ju Ryu is an academic researcher from Samsung (South Korea). The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Immune Cell Function and Interaction & Chronic Lymphocytic Leukemia Research. The author has an h-index of 17, co-authored 35 publications.
ORCID: 0000-0003-0986-1475Papers by this author
worksMacrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma
2016 · Hematological Oncology · 18 citations
https://doi.org/10.1002/hon.2283
A subset of CD45+/CD19 − cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma
2015 · Leukemia & lymphoma/Leukemia and lymphoma · 5 citations
https://doi.org/10.3109/10428194.2015.1025391
Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience
2014 · Blood · 0 citations
https://doi.org/10.1182/blood.v124.21.1622.1622
MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-90542-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat